• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Australia·Healthcare·TD1.AX
Share

TALi Digital Limited Stocks

A$ 0.08Last Updated 31.07.2026

Issuer Rating

2/7
Performance

Modest

Risk

High

Recommendation

Sell

Market Cap

A$ 2.19M

A$ 0.08
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

TALi Digital Limited is an Australian digital health firm dedicated to improving cognitive function and behavior through its diagnostic and therapeutic offerings. The company provides TALi DETECT, an evidence-based digital screening program lasting 20-30 minutes, which utilizes cognitive assessments to gauge a child's attention skills relative to their peers. Complementing this is TALi TRAIN, a digital cognitive training solution designed to enhance selective attention and numeracy, and in certain cases, alleviate inattentive and hyperactive behaviors in children. The company maintains a significant licensing agreement with Akili Interactive Labs, Inc. for pediatric cognitive products. Founded in 2004, the enterprise, headquartered in Camberwell, was formerly known as Novita Healthcare Limited until its name change in December 2019.

Company Valuation

Fairly valued
4/7

Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

31.07.2026 18:00

The U.S. dollar is poised for its worst week in three months

31.07.2026 17:59

Freedom Holding has completed the acquisition of a bank in Turkey

31.07.2026 17:20

Gold is on track for its first monthly price increase since February. What will happen next?

31.07.2026 16:53

Shares of the IT company Cycurion soared 500%. It has secured the largest contract in its history.

31.07.2026 16:05

Inflation in the eurozone accelerated in July due to rising oil prices. What will happen to interest rates?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026